EP3472317
SAMSETNINGAR OG AÐFERÐIR TIL AÐ DRAGA ÚR NÝÆÐAMYNDUN Í AUGUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.6.2017EP published:
16.3.2022EP application number:
17814228.7
EP translation filed:
25.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
15.6.2037Expiry date:
15.6.2026Next due date:
30.6.2026
Title in English:
COMPOSITIONS AND METHODS FOR REDUCING OCULAR NEOVASCULARIZATIONLanguage of the patent:
English
Timeline
Today
16.6.2017EP application
16.3.2022EP Publication
25.5.2022Translation submitted
15.6.2022Registration published
15.6.2026Expires
Owner
Name:
Adverum Biotechnologies, Inc.Address:
800 Saginaw Drive, Redwood City, CA 94063, US
Inventor
Name:
BLUMENKRANZ, MarkAddress:
Menlo Park, CA 94025, US
Name:
GASMI, MehdiAddress:
Menlo Park, CA 94025, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201662351231 PDate:
16.6.2016Country:
US
Classification
Categories:
C12N 15/09, C12N 15/86, C12N 15/861, C07K 14/705, C07K 14/005, A61K 38/17, A61F 9/008, A61K 39/395, A61K 48/00, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.5.2022
Expires: 15.6.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 24.5.2023
Expires: 15.6.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.6.2024
Expires: 15.6.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 10.6.2025
Expires: 15.6.2026
Payer: G.H. Sigurgeirsson ehf.